Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s near-term focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition.
Location: Sweden, Stockholm
Member count: 1-10
Total raised: $23.133091M
Founded date: 2011
Investors 2
Date | Name | Website |
19.02.2021 | HealthCap | healthcap.... |
- | Karolinska... | karolinska... |
Funding Rounds 3
Date | Series | Amount | Investors | Deal News |
15.07.2021 | - | $3.810126M | - | marketscre... |
13.07.2018 | - | $15.756512... | - | finsmes.co... |
21.02.2017 | - | $3.566453M | - | finsmes.co... |
Mentions in press and media 39
Date | Title | Description | Category | Author | Source |
22.11.2022 | Modus Ther... | Modus Therapeutics publishes i... | - | - | news.cisio... |
01.09.2022 | Modus Ther... | Modus Therapeutics announces f... | - | - | news.cisio... |
23.08.2022 | Modus Ther... | Modus Therapeutics publishes i... | - | - | news.cisio... |
10.06.2022 | Modus Ther... | Modus Therapeutics presents at... | - | - | news.cisio... |
25.05.2022 | Modus Ther... | Modus Therapeutics Updates on ... | - | - | news.cisio... |
16.05.2022 | Modus Ther... | Modus Therapeutics publishes i... | - | - | news.cisio... |
12.05.2022 | Modus Ther... | Modus Therapeutics secures acc... | - | - | news.cisio... |
11.05.2022 | Annual Gen... | Annual General Meeting in Modu... | - | - | news.cisio... |
22.04.2022 | New public... | New publication date for Modus... | - | - | news.cisio... |
19.04.2022 | Modus Ther... | Modus Therapeutics Holding AB ... | - | - | news.cisio... |
Show more